US Renal Data System.Excerpts from the USRDS 1997 Annual Data Report. Am J Kidney Dis1997; 30(suppl): S1–195.
2.
ParfeyP.S., FoleyR.N.The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol1999; 10: 1606–15.
3.
FoleyR.N., ParfreyP.S., SarnakM.J.Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis1998; 32(suppl 5): S112–9.
4.
US Renal Data System.Excerpts from the USRDS 2001 Annual Data Report. Am J Kidney Dis2001; 38(suppl): S1–248.
5.
BraunwaldE.Shattuck lecture – Cardiovascular medicine at the turn of the millennium: Triumphs, concerns and opportunities. N Engl J Med1997; 337: 1360–9.
DegouletP., LegrainM., ReachI.Mortality risk factors in patients treated by chronic hemodialysis. Nephron1982; 31: 103–10.
8.
LowrieE.G., LewN.L.Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis1990; 15: 458–82.
9.
CharraB., CalemardE., LaurentG.Importance of treatment time and blood pressure in achieving long-term survival on dialysis. Am J Nephrol1996; 16: 35–44.
10.
ZagerP.G., NikolicJ., BrownR.“U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int1998; 54: 561–9.
11.
MaJ.Z., EbbenJ., XiaH., CollinsA.J.Haematocrit level and associated mortality in haemodialysis patients. J Am Soc Nephrol1999; 10: 610–9.
12.
BlockG.A., Hulbert-ShearonT.E., LevinN.W., PortF.K.Association of serum phosphorus and calciumxphosphate product with mortality risk in chronic haemodialysis patients: a national study. Am J Kidney Dis1998; 31: 607–17.
13.
Investigators CREED(Cardiovascular Risk Extended Evaluation in Dialysis Patients): C-reactive protein and atherosclerosis in dialysis patients. Nephrol Dial Transplant1998; 13: 2710–11.
14.
MoustaphaA., NasoA., NahlawiM.Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation1998; 97: 138–41.
15.
RossR.Atherosclerosis: an inflammatory disease. N Engl J Med1999; 340: 115–26.
16.
RidkerP.M., CushmanM., StampferM.J.Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med1997; 336: 973–9.
17.
LiuzzoG., BiasucciL.M., GallimoreJ.R.The prognostic value of C-reactive protein an serum amyloid A protein in severe unstable angina. N Engl J Med1994; 331: 417–24.
18.
LagrandW.K., VisserC.A., HermensW.T.C-reactive-protein as a cardiovascular risk: more than an epiphenomenon?Circulation1999; 100: 96–102.
19.
TorzewskiJ., TorzewskiM., BowyerD.E.C-reactive protein frequently localizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol1998; 18: 1386–92.
20.
LagrandW.K., NiessenH.W.M., WolbinkG.J.C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation1997; 95: 97–103.
21.
StenvinkelP.Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif2001; 19: 143–51.
22.
KaysenG.A.Role of Inflammation and its treatment in ESRD patients. Blood Purif2002; 20: 70–80.
23.
BrancaccioD., TettaC., GallieniM., PanichiV.Inflammation, CRP, calcium overload and a high calcium-phosphate product: a “liaison dangereuse”. Nephrol Dial Transplant2002; 17: 201–03.
24.
ZimmermannJ., HerrlingerS., PruyA.Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int1999; 55: 648–58.
25.
IkizlerT.A., WingardR.L., HarvellJ.Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int1999; 55: 1945–51.
26.
YeunJ.Y., LevineR.A., MantadilokV., KaysenG.A.C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis2000; 35: 469–76.
27.
BologaR.M., LevineD.M., ParkerT.S.Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis1998; 32: 107–14.
28.
NohH., LeeS.W., KangS.W.Serum C-reactive protein: a predictor of mortality in continous ambulatory peritoneal dialysis. Perit Dial Int1998; 18: 387–94.
29.
QuereshiA.R., AlvestrandA., DanielssonA.Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int1998; 53: 773–82.
30.
StenvinkelP., HeinburgerO., PaultreF.Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int1999; 55: 1899–911.
31.
KaysenG.A., DublinJ.A., MullerH.G.The acute phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int2000; 58: 346–52.
32.
KingA.J., KehayiasJ.J., RoubenoffR.Cytokine production and nutritional status in hemodialysis patients. Int J Artif Organs1998; 21: 4–11.
33.
SethiD., MullerB.R., BrownE.A.C-reactive protein in haemodialysis patients with dialysis arthropathy. Nephrol Dial Transplant1988; 3: 269–71.
34.
PanichiV., MiglioriM., De PietroS.C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron2002; 91: 594–600.
35.
van Riemsdijk-van OverbeekeI.C., BaanC.C., HesseC.J.TNF-α mRNA, plasma protein levels and soluble receptors in patients with chronic hemodialysis, on CAPD and with end-stage renal failure. Clin Nephrol2000; 53: 115–23.
36.
TrznadelK., LuciakM., ParadowskiM., Kubasiewicz-UjmaB.Hemodialysis and the acute-phase response in chronic uremic patients. Int J Artif Organs1989; 12: 762–5.
37.
HaubitzM., BrunkhorstR., WrengenE.Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis. Perit Dial1996; 16: 158–62.
38.
TettaC., GallieniM., PanichiV., BrancaccioD.Vascular calcifications as a footprint of increased calcium load and chronic inflammation in uremic patients: a need for a neutral calcium balance during hemodialysis?Int J Artif Organs2002; 25: 18–26.
39.
StenvinkelP., HeimburgerO., Jogestrand. Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure?Kidney Int1999; 55: 2531–2.
40.
Cardiovascular Risk Extended Evaluation in Dialysis Patients (CREED): C-reactive protein and atherosclerosis in dialysis patients. Nephrol Dial Transplant1998; 13: 2710–11.
41.
SpittleM., CraigR., AdhikarlaR.Relationship between antibodies to peridontal pathogens and C-reactive protein levels in hemodialysis patients. J Am Soc Nephrol2000; 11: 299A.
42.
SchoutenW.E.M., GrootemanM.P.C., van HouteA.J.Effects of dialysers and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant2000; 15: 379–84.
43.
DocciD., BilancioniR., BuscaroliA.Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron1990; 56: 364–7.
44.
HonkanenE., Gronhagen-RiskaC., TeppoA.M.Acute-phase proteins during hemodialysis: Correlations with serum interleukin-1 levels and different dialysis membranes. Nephron1991; 57: 2837.
45.
TielemansC., HussonC., SchurmansT.Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis. Kidney Int1996; 49: 236–43.
46.
SchindlerR., BoenischO., FischerC., FreiU.Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol2000; 53: 452–9.
47.
PanichiV., MiglioriM., De PietroS.Plasma C-reactive protein in hemodialysis patients: a cross sectional, longitudinal clinical survey. Blood Purif2000; 18: 30–6.
48.
PanichiV., MiglioriM., De PietroS.The link of biocompatibility to cytokine production. Kidney Int2000; 58(suppl 76): S96–S103.
49.
RidkerP.M., RifaiN., PfefferM.A.Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation1999; 100: 230–35.
50.
RidkerP.M., RifaiN., ClearfieldM.Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators: Measurements of C-reactive protein for targeting of statins therapy in the primary prevention of acute coronary events. N Engl J Med2001; 344: 1959–65.
51.
KarimM.Y., Ruiz-IrastorzaG., KhamashtaM.A.Update on therapy- Thalidomide in the treatment of lupus. Lupus2001; 10: 188–92.
52.
PereiraB.J., DinarelloC.A.Role of cytokines in patients on dialysis. Int J Artif Organs1995; 18: 293–304.
